Soner Altiok

4.6k total citations · 1 hit paper
60 papers, 3.5k citations indexed

About

Soner Altiok is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Soner Altiok has authored 60 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 25 papers in Molecular Biology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Soner Altiok's work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Histone Deacetylase Inhibitors Research (6 papers). Soner Altiok is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Histone Deacetylase Inhibitors Research (6 papers). Soner Altiok collaborates with scholars based in United States, Germany and United Kingdom. Soner Altiok's co-authors include Bruce M. Spiegelman, Min Xu, Eric B. Haura, Dmitry I. Gabrilovich, Esteban Celis, Rupal Ramakrishnan, Regina P. Brun, Jenny Kreahling, Hyun-Il Cho and Samuel Singer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Soner Altiok

59 papers receiving 3.5k citations

Hit Papers

Terminal differentiation of human liposarcoma cells induc... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers

Soner Altiok
Raphael A. Nemenoff United States
Yiyu Zou United States
Shan Zha United States
Edgar Selzer Austria
Keith Syson Chan United States
Robert D. Loberg United States
Pixu Liu China
Raphael A. Nemenoff United States
Soner Altiok
Citations per year, relative to Soner Altiok Soner Altiok (= 1×) peers Raphael A. Nemenoff

Countries citing papers authored by Soner Altiok

Since Specialization
Citations

This map shows the geographic impact of Soner Altiok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soner Altiok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soner Altiok more than expected).

Fields of papers citing papers by Soner Altiok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soner Altiok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soner Altiok. The network helps show where Soner Altiok may publish in the future.

Co-authorship network of co-authors of Soner Altiok

This figure shows the co-authorship network connecting the top 25 collaborators of Soner Altiok. A scholar is included among the top collaborators of Soner Altiok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soner Altiok. Soner Altiok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gray, Jhanelle E., Alberto Chiappori, Tawee Tanvetyanon, et al.. (2018). A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma. Cancer Immunology Immunotherapy. 67(12). 1853–1862. 29 indexed citations
2.
Mediavilla-Varela, Melanie, Jenny Kreahling, Bruce Freimark, et al.. (2017). Effect of bavituximab in combination with nivolumab on tumor immune response in a 3D ex vivo system of lung cancer patients.. Journal of Clinical Oncology. 35(15_suppl). e23091–e23091. 1 indexed citations
3.
Song, Lanxi, Matthew A. Smith, Parul Doshi, et al.. (2014). Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer. Journal of Thoracic Oncology. 9(7). 974–982. 85 indexed citations
4.
Kreahling, Jenny, Parastou Foroutan, Damon R. Reed, et al.. (2013). Wee1 Inhibition by MK-1775 Leads to Tumor Inhibition and Enhances Efficacy of Gemcitabine in Human Sarcomas. PLoS ONE. 8(3). e57523–e57523. 75 indexed citations
5.
Ramakrishnan, Rupal, Chun Huang, Hyun-Il Cho, et al.. (2012). Autophagy Induced by Conventional Chemotherapy Mediates Tumor Cell Sensitivity to Immunotherapy. Cancer Research. 72(21). 5483–5493. 90 indexed citations
6.
Bai, Yun, Jiannong Li, Bin Fang, et al.. (2012). Phosphoproteomics Identifies Driver Tyrosine Kinases in Sarcoma Cell Lines and Tumors. Cancer Research. 72(10). 2501–2511. 98 indexed citations
7.
Gray, Jhanelle E., Soner Altiok, Frank Walsh, et al.. (2012). Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers. Cancer. 119(5). 1023–1032. 9 indexed citations
8.
Singh, Sandeep, José G. Treviño, Namrata Bora-Singhal, et al.. (2012). EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Molecular Cancer. 11(1). 73–73. 209 indexed citations
9.
Пили, Роберто, Brenda Salumbides, Ming Zhao, et al.. (2011). Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours. British Journal of Cancer. 106(1). 77–84. 125 indexed citations
10.
Alexandrow, Mark G., et al.. (2011). Curcumin. European Journal of Cancer Prevention. 21(5). 407–412. 98 indexed citations
11.
Tanvetyanon, Tawee, Lary A. Robinson, K. Eric Sommers, et al.. (2010). Relationship between Tumor Size and Survival among Patients with Resection of Multiple Synchronous Lung Cancers. Journal of Thoracic Oncology. 5(7). 1018–1024. 27 indexed citations
12.
Kreahling, Jenny, et al.. (2010). Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer Cells. PLoS ONE. 5(12). e14335–e14335. 60 indexed citations
13.
Zhang, Guolin, Bin Fang, Hui‐Yi Lin, et al.. (2010). Mass Spectrometry Mapping of Epidermal Growth Factor Receptor Phosphorylation Related to Oncogenic Mutations and Tyrosine Kinase Inhibitor Sensitivity. Journal of Proteome Research. 10(1). 305–319. 51 indexed citations
14.
Altıok, Nedret, et al.. (2007). A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1. Breast Cancer Research and Treatment. 109(2). 315–323. 20 indexed citations
15.
Wu, Julie M., Soner Altiok, & Syed Z. Ali. (2005). A 49-Year-Old Woman With a Recurring Painful Soft Tissue Ankle Mass. Archives of Pathology & Laboratory Medicine. 129(9). 1187–1188. 1 indexed citations
16.
Altiok, Soner. (2003). Molecular markers in cervical cytology. Clinics in Laboratory Medicine. 23(3). 709–728. 3 indexed citations
17.
Altiok, Soner, Min Xu, & Bruce M. Spiegelman. (1997). PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes & Development. 11(15). 1987–1998. 322 indexed citations
18.
Brun, Regina P., Jae Bum Kim, Erding Hu, Soner Altiok, & Bruce M. Spiegelman. (1996). Adipocyte differentiation: a transcriptional regulatory cascade. Current Opinion in Cell Biology. 8(6). 826–832. 150 indexed citations
19.
Altiok, Soner & Bernd Groner. (1994). β-Casein mRNA Sequesters a Single-Stranded Nucleic Acid-Binding Protein Which Negatively Regulates the β-Casein Gene Promoter. Molecular and Cellular Biology. 14(9). 6004–6012. 37 indexed citations
20.
Groner, Bernd, Soner Altiok, & Verena Meier. (1994). Hormonal regulation of transcription factor activity in mammary epithelial cells. Molecular and Cellular Endocrinology. 100(1-2). 109–114. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026